Back to Newsroom

Sucampo Pharmaceuticals Announces Presentation at Deutsche Bank’s 25th Annual Leveraged Finance Conference

ROCKVILLE, Md., Sept. 27, 2017 (GLOBE NEWSWIRE) — Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that the company will participate in Deutsche Bank’s 25thAnnual Leveraged Finance Conference on Wednesday, October 4th at 2:15PM Mountain.